DR. NICO COENEN

Active

Private limited companyfounded 2006active for 20 yearsLuikersteenweg 129, 3500 Hasselt, BelgiumKBO/BCE: BE 0884.593.181

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. NICO COENEN has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €247,301 and a net result of €38,884. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 75% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR. NICO COENENActiveChecked score 97/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 26-10-2006 Normal situation
Legal form: Private limited company
Registered office: Luikersteenweg 129, 3500 Hasselt
Activity: Other research and development on natural sciences NACE 72109and 1 other
Establishment unit: 2.159.861.287 3500 Hasselt, since 27-02-2007
Financial year end: 31 December
Peppol: Reachable since 21-11-2025

Company details

Who decides

Board

COENEN NicoDirector · since 24-10-2006

Board & ownership

How it is doing

97 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €180,890; ▲ 8.6%
Turnover: ≈ €450,000; estimated
Profit: €38,884; ▲ 13.9%
Equity: €247,301; ▲ 18.7%
Total assets: €291,450; ▲ 7.9%
Staff: 2 FTE; =

2025 accounts 24 days early

Filed on 07-07-2026at the National Bank

Financials

Why 97lowers riskLiquidity: current ratio 5.70, cash €209,231Equity €247,301 (84.9% of total assets)Size: total assets €291,450Founded in 2006Show the evidence

Checked score

Score 2025

97 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 77% of its sector peers (NACE 72, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 84.9% of total assets

Liquidity 98=

short-term debt 13.2% · cash 71.8%

Profitability 85=

return on assets 13.3%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €23,000 on 30-day terms is acceptable

Liquidity ample (current ratio 5.7, compared with 5.89 in 2024, above the usual 1.5; short-term debt: 13.2% and cash: 71.8% of total assets), and 15.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 89% on liquidity, 63% on profitability and 71% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 5.70, cash €209,231

NBB · annual accounts

Equity €247,301 (84.9% of total assets)

NBB · annual accounts

Size: total assets €291,450

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Founded in 2006

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

24 days early

2024

14 days early

2023

20 days early

2022

24 days early

2021

30 days early

2020

24 days early

2019

23 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 23 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

31-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Positive: 8 profitable years in a rowprofit 2025: €38,884 8 years View

Documents

Key facts about DR. NICO COENEN

What is the company number of DR. NICO COENEN?: 0884.593.181. In Belgium the VAT number is the company number with BE in front: BE 0884.593.181.
Where is DR. NICO COENEN based?: The registered office is at Luikersteenweg 129, 3500 Hasselt.Company details
What does DR. NICO COENEN do?: According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of DR. NICO COENEN?: Private limited company (BV).
When was DR. NICO COENEN founded?: On 26-10-2006.
Is DR. NICO COENEN still active?: Yes, DR. NICO COENEN is an active enterprise in the KBO register.
How many employees does DR. NICO COENEN have?: On average 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR. NICO COENEN?: ≈ €450,000 in financial year 2025. Estimated from the gross margin of €180,890: probably between €300,000 and €700,000, based on 2,210 comparable companies of the same size. A rough estimate.
Is DR. NICO COENEN profitable?: In financial year 2025, DR. NICO COENEN made a profit of €38,884.
Where can I find the annual accounts of DR. NICO COENEN?: DR. NICO COENEN filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. NICO COENEN due?: By 31-07-2027, for financial year 2026.Timeline